DexCom, Inc. (DXCM)
77.94
-0.38
(-0.49%)
USD |
NASDAQ |
Oct 23, 16:00
77.98
+0.04
(+0.05%)
After-Hours: 20:00
DexCom Total Long Term Debt (Quarterly) : 1.378B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.378B |
| March 31, 2026 | 1.364B |
| December 31, 2025 | 1.368B |
| September 30, 2025 | 2.552B |
| June 30, 2025 | 2.556B |
| March 31, 2025 | 2.561B |
| December 31, 2024 | 2.565B |
| September 30, 2024 | 2.569B |
| June 30, 2024 | 2.573B |
| March 31, 2024 | 2.569B |
| December 31, 2023 | 2.573B |
| September 30, 2023 | 2.698B |
| June 30, 2023 | 3.350B |
| March 31, 2023 | 2.121B |
| December 31, 2022 | 2.124B |
| September 30, 2022 | 2.111B |
| June 30, 2022 | 2.116B |
| March 31, 2022 | 2.121B |
| December 31, 2021 | 2.137B |
| September 30, 2021 | 1.864B |
| June 30, 2021 | 1.875B |
| March 31, 2021 | 1.854B |
| December 31, 2020 | 1.823B |
| September 30, 2020 | 1.803B |
| June 30, 2020 | 1.746B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.164B |
| December 31, 2019 | 1.146B |
| September 30, 2019 | 1.096B |
| June 30, 2019 | 1.087B |
| March 31, 2019 | 1.067B |
| December 31, 2018 | 1.018B |
| September 30, 2018 | 346.10M |
| June 30, 2018 | 342.30M |
| March 31, 2018 | 338.70M |
| December 31, 2017 | 334.30M |
| September 30, 2017 | 330.70M |
| June 30, 2017 | 327.20M |
| March 31, 2017 | 6.70M |
| December 31, 2016 | 6.00M |
| September 30, 2016 | 6.00M |
| June 30, 2016 | 6.00M |
| March 31, 2016 | 1.70M |
| December 31, 2015 | 2.30M |
| September 30, 2015 | 2.90M |
| June 30, 2015 | 3.50M |
| March 31, 2015 | 4.10M |
| December 31, 2014 | 4.60M |
| September 30, 2014 | 5.20M |
| June 30, 2014 | 5.80M |
| March 31, 2014 | 6.30M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Abbott Laboratories | 0.00 |
| Baxter International, Inc. | 8.857B |
| Stryker Corp. | 15.29B |
| Becton, Dickinson & Co. | 16.81B |
| Insulet Corp. | 948.40M |